NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Atopic Dermatitis in Practice: Case Studies from Diagnosis to Treatment

EP. 1: From Biopsy to Treatment: Overcoming Diagnostic Challenges in Atopic Dermatitis

ByAndrea Rosik, PA-C
August 6th 2024

EP. 2: Exploring Novel Non-Steroidal Topicals and Their Role in Dermatitis Care

ByAndrea Rosik, PA-C
August 6th 2024

EP. 3: FDA Approved Treatments: Topical Ruxolitinib and Vitiligo Management

ByAndrea Rosik, PA-C
August 6th 2024

EP. 4: Alternative Treatments and In-Office Samples for Atopic Dermatitis Management

ByAndrea Rosik, PA-C
August 6th 2024

EP. 5: Exploring the Atopic Dermatitis Treatment Paradigm and Challenging Cases: Part 2

ByEmma Andrus, Associate Editor
November 22nd 2024

Andrea Rosik, MS, PA-C, provides insights into managing challenging cases of atopic dermatitis.

Advertisement
Advertisement

Trending on Dermatology Times

1

FDA Grants Breakthrough Therapy Designation to Litifilimab for Cutaneous Lupus Erythematosus

2

Phase 2b Analysis Shows Consistent Vitiligo Repigmentation With Ritlecitinib

3

Dual ITK/JAK3 Inhibition Shows Strong Preclinical Activity in Severe Alopecia Areata

4

On the Horizon: Innovations in the Acne Treatment Pipeline

5

FAQtual Insights: Safe Approaches to Off Label Prescribing

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us